ClinConnect ClinConnect Logo
Search / Trial NCT02027129

Physiological Study of Low-frequency HFO/HFO-TGI and High-frequency HFO

Launched by UNIVERSITY OF ATHENS · Jan 2, 2014

Trial Information

Current as of June 07, 2025

Completed

Keywords

Respiratory Distress Syndrome, Adult Cor Pulmonale High Frequency Ventilaiton

ClinConnect Summary

Rationale of the study Acute Respiratory Distress Syndrome (ARDS) is an acute inflammatory state of the pulmonary parenchyma that causes hypoxemia, atelectasis, pulmonary congestion, and reduction in pulmonary compliance. Mechanical ventilation is actually life-saving, but it may traumatize the lungs (e.g. volutrauma, barotrauma, atelectrauma, and biotrauma). The use of low tidal volumes and high positive end-expiratory pressure (PEEP), aims at attenuating ventilator-associated lung injury. However, ARDS mortality still remains high. High frequency oscillation (HFO) is an alternative ventil...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Acute Respiratory Distress Syndrome (ARDS) according to the Berlin Definition Onset of ARDS within the 72 hours preceding study enrollment PaO2/FiO2 of less than 150 mmHg while ventilated with a positive end-expiratory pressure of at least 10 cmH2O Body weight of more than 40 Kg Age 18-75 years
  • Exclusion Criteria:
  • Severe air leak (more than one chest tubes per hemithorax with persistent air leak for more than 72 hours) Systolic blood pressure lower than 90 mmHg, despite maximum support with fluids and vasopressor drugs Significant heart disease Severe chronic obstructive pulmonary disease or asthma Intracranial hypertension Chronic interstitial lung disease with bilateral lung infiltrates Lung biopsy or incision during the current admission Previous lung transplantation or bone marrow transplantation Pregnancy

About University Of Athens

The University of Athens, a leading institution in medical research and education, is dedicated to advancing healthcare through innovative clinical trials. With a robust infrastructure and a multidisciplinary team of experts, the university focuses on translating scientific discoveries into practical applications that benefit patient care. Its commitment to ethical standards and rigorous methodologies ensures that all trials conducted under its auspices adhere to the highest principles of research integrity. By fostering collaboration with national and international partners, the University of Athens aims to contribute significantly to the global medical community and improve health outcomes through evidence-based practices.

Locations

Athens, Attica, Greece

Patients applied

0 patients applied

Trial Officials

Spyros D Mentzelopoulos, MD, PhD

Principal Investigator

University of Athens Medical School, Dept. Intensive Care Medicine

Spyros G Zakynthinos, MD, PhD

Study Chair

University of Athens Medical School, Dept. Intensive Care Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials